Fadel S. Alyaqoub, Ph.D. - Publications
Affiliations: | 2005 | Medical College of Ohio, Toledo, OH, United States |
Area:
Molecular Biology, PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Alyaqoub FS, Liu Y, Tao L, Steele VE, Lubet RA, Pereira MA. Modulation by bexarotene of mRNA expression of genes in mouse lung tumors. Molecular Carcinogenesis. 47: 165-71. PMID 17849452 DOI: 10.1002/Mc.20383 | 0.598 | |||
2007 | Alyaqoub FS, Tao L, Kramer PM, Steele VE, Lubet RA, Gunning WT, Pereira MA. Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (Zarnestra MT). Carcinogenesis. 28: 124-9. PMID 16885199 DOI: 10.1093/Carcin/Bgl136 | 0.645 | |||
2006 | Alyaqoub FS, Tao L, Kramer PM, Steele VE, Lubet RA, Gunning WT, Pereira MA. Prevention of mouse lung tumors and modulation of DNA methylation by combined treatment with budesonide and R115777 (ZarnestraMT). Carcinogenesis. 27: 2442-7. PMID 16733249 DOI: 10.1093/carcin/bgl088 | 0.693 | |||
2006 | Pereira MA, Kramer PM, Nines R, Liu Y, Alyaqoub FS, Gunning WT, Steele VE, Lubet RA. Prevention of mouse lung tumors by targretin. International Journal of Cancer. Journal International Du Cancer. 118: 2359-62. PMID 16331605 DOI: 10.1002/ijc.21618 | 0.657 | |||
Show low-probability matches. |